Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 65

Sort by

Sort Order Select

Journal Articles

Phase I Safety Study of Anti-Transferrin Receptor 1 Antibody (PPMX-T003) in Patients with Polycythemia Vera and Erythrocythemia

Tomoki Ito, Teruhito Takakuwa, Masayuki Hino, Hirohisa Nakamae, Kazunori Murai, Yoko Kubuki, Kazuya Shimoda, Yuji Kumagai, Yukiya Yamamoto, Tadashi Matsuura

Blood (2024) 144 (Supplement 1): 4542.

https://doi.org/10.1182/blood-2024-206911

Published: 2024

Journal Articles

The Diagnostic Accuracy of the Refined EBMT Criteria 2023 for SOS

Seidai Tanaka, Hiroshi Okamura, Soichiro Nakako, Makoto Moriguchi, Kentaro Ido, Kazuki Sakatoku, Yosuke Nakaya, Mirei Horiuchi, Yosuke Makuuchi, Masatomo Kuno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Mika Nakamae, Masayuki Hino, Hirohisa Nakamae

Blood (2024) 144 (Supplement 1): 4861.

https://doi.org/10.1182/blood-2024-201643

Published: 2024

Journal Articles

Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera

Tomoki Ito, Teruhito Takakuwa, Masayuki Hino, Hirohisa Nakamae, Tadashi Matsuura

Blood (2023) 142 (Supplement 1): 1825.

https://doi.org/10.1182/blood-2023-174193

Published: 2023

Journal Articles

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

Soichiro Nakako, Hiroshi Okamura, Isao Yokota, Yukari Umemoto, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Mitsutaka Nishimoto, Asao Hirose, Mika Nakamae, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino, Hirohisa Nakamae

Blood (2022) 140 (Supplement 1): 3416–3418.

https://doi.org/10.1182/blood-2022-164932

Published: 2022

Journal Articles

Efficacy and Safety of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: Final 3-Year Results of a Phase 2 Study

Takaaki Ono, Masayuki Hino, Itaru Matsumura, Shin Fujisawa, Kenichi Ishizawa, Emiko Sakaida, Naohiro Sekiguchi, Chiho Ono, Mana Aizawa, Yusuke Tanetsugu, Yuichiro Koide, Naoto Takahashi

Blood (2021) 138 (Supplement 1): 2557.

https://doi.org/10.1182/blood-2021-145164

Published: 2021

Journal Articles

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Naonori Harada, Hiroshi Okamura, Hideo Koh, Nao Tanizawa, Yosuke Makuuchi, Masatomo Kuno, Teruhito Takakuwa, Asao Hirose, Mika Nakamae, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hirohisa Nakamae, Masayuki Hino

Blood (2021) 138 (Supplement 1): 2865.

https://doi.org/10.1182/blood-2021-146497

Published: 2021

Journal Articles

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Naonori Harada, Hiroshi Okamura, MD PhD, Takahiko Nakane, MD PhD, Shiro Koh, MDPhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-134223

Published: 2020

Journal Articles

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Kentaro Ido, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Shiro Koh, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 2030.

https://doi.org/10.1182/blood-2019-125173

Published: 2019

Journal Articles

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Nao Tanizawa, MD, Hideo Koh, MD PhD, Hiroshi Okamura, MD PhD, Koh Shiro, MD PhD, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Asao Hirose, MD PhD, Mika Nakamae, MD PhD, Yasuhiro Nakashima, MD PhD, Takahiko Nakane, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2019) 134 (Supplement_1): 4492.

https://doi.org/10.1182/blood-2019-124264

Published: 2019

Journal Articles

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Naoto Takahashi, MD PhD, Itaru Matsumura, MD PhD, Shin Fujisawa, MD, Kenichi Ishizawa, MD PhD, Takaaki ONO, MD PhD, Emiko Sakaida, MD PhD, Naohiro Sekiguchi, MD PhD, Yusuke Tanetsugu, Kei Fukuhara, Masayuki Ohkura, Yuichiro Koide, Masayuki Hino, MD PhD

Blood (2019) 134 (Supplement_1): 4159.

https://doi.org/10.1182/blood-2019-121809

Published: 2019

Journal Articles

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

Naonori Harada, Takahiko Nakane, MD PhD, Mika Nakamae, MD PhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MD PhD, Yasunobu Takeoka, MD PhD, Asao Hirose, MD PhD, Yasuhiro Nakashima, MD PhD, Hideo Koh, MD PhD, Masayuki Hino, MD PhD, Hirohisa Nakamae, MD PhD

Blood (2018) 132 (Supplement 1): 4664.

https://doi.org/10.1182/blood-2018-99-111679

Published: 2018

Journal Articles

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Kentaro Ido, MD, Mika Nakamae, MDPhD, Hideo Koh, MDPhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MDPhD, Yoshinori Hashimoto, MD, Yasunobu Takeoka, MDPhD, Asao Hirose, MDPhD, Yasuhiro Nakashima, MDPhD, Takahiko Nakane, MD PhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2018) 132 (Supplement 1): 4665.

https://doi.org/10.1182/blood-2018-99-111834

Published: 2018

Journal Articles

Noninvasive Diagnostic Approach By per Rectal Portal Scintigraphy for Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation

Blood (2018) 132 (Supplement 1): 2087.

https://doi.org/10.1182/blood-2018-99-110517

Published: 2018

Journal Articles

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)

Blood (2018) 132 (Supplement 1): 1753.

https://doi.org/10.1182/blood-2018-99-115129

Published: 2018

Journal Articles

Results from the 208-Week (4-Year) Follow-up of RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera (PV)

Blood (2017) 130 (Supplement 1): 322.

https://doi.org/10.1182/blood.V130.Suppl_1.322.322

Published: 2017

Journal Articles

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Satoru Nanno, MDPhD, Hideo Koh, MDPhD, Mitsutaka Nishimoto, MDPhD, Takahiko Nakane, MDPhD, Yasuhiro Nakashima, MDPhD, Yasunobu Takeoka, MDPhD, Mika Nakamae, MDPhD, Asao Hirose, MDPhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD

Blood (2017) 130 (Supplement 1): 1965.

https://doi.org/10.1182/blood.V130.Suppl_1.1965.1965

Published: 2017

Journal Articles

Post-Transplant Cyclophosphamide Contributes to Impaired Graft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model

Yosuke Makuuchi, MD, Yasuhiro Nakashima, MDPhD, Hideo Koh, MDPhD, Takahiko Nakane, MDPhD, Hirohisa Nakamae, MDPhD, Masayuki Hino, MDPhD

Blood (2017) 130 (Supplement 1): 4448.

https://doi.org/10.1182/blood.V130.Suppl_1.4448.4448

Published: 2017

Journal Articles

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Hiroshi Okamura, MD, Mitsutaka Nishimoto, MD,PhD, Takahiko Nakane, MD, PhD, Hideo Koh, MD,PhD, Yasuhiro Nakashima, MD, PhD, Yasunobu Takeoka, MD, PhD, Mika Nakamae, MD,PhD, Asao Hirose, MD, PhD, Masayuki Hino, MD, PhD, Hirohisa Nakamae, MD PhD

Blood (2016) 128 (22): 5755.

https://doi.org/10.1182/blood.V128.22.5755.5755

Published: 2016

Journal Articles

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

Kazuki Sakatoku, MD, Yasunobu Takeoka, MD, PhD, Taku Araki, MD, Ryosuke Yamamura, MD, PhD, Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD PhD, Masayuki Hino, MD, PhD, Kensuke Ohta, MD, PhD

Blood (2016) 128 (22): 1995.

https://doi.org/10.1182/blood.V128.22.1995.1995

Published: 2016

Journal Articles

Short-Term Fasting Induces Cell Cycle Arrest of Immature Hematopoietic Cells and Increases the Number of Naive T Cells in the Bone Marrow of Mice

Teruhito Takakuwa, MD, Yasuhiro Nakashima, MD, PhD, Hideo Koh, MD,PhD, Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD PhD, Masayuki Hino, MD, PhD

Blood (2016) 128 (22): 5047.

https://doi.org/10.1182/blood.V128.22.5047.5047

Published: 2016

NARROW

Phase I Safety Study of Anti-Transferrin Receptor 1 Antibody (PPMX-T003) in Patients with Polycythemia Vera and Erythrocythemia

The Diagnostic Accuracy of the Refined EBMT Criteria 2023 for SOS

Interim Phase I Safety Study of Anti-Transferrin Receptor Antibody(PPMX-T003) in Patients with Polycythemia Vera

Time-Sequential Change of the Predictive Power of Peripheral Blood WT1mRNA Levels after Allogeneic Stem Cell Transplantation for Myeloid Neoplasm Relapse and Development of a Dynamic Relapse Prediction Model

Efficacy and Safety of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: Final 3-Year Results of a Phase 2 Study

A Prospective Comparison Analysis of Blood Biomarkers for the Diagnosis and Prediction of Sinusoidal Obstruction Syndrome

Pretransplant Plasma Brain Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide Are More Useful Prognostic Markers of Overall Survival after Allogeneic Hematopoietic Cell Transplantation Than Echocardiography

Impact of Donor KIR and HLA Genotypes on Clinical Outcomes According to Pre-Transplant Remission Status after HLA-Haploidentical Transplantation with Post-Transplantation Cyclophosphamide

Pretransplant Risk Factors for Calcineurin Inhibitor-Induced Encephalopathy and Limbic Encephalitis Following Allogeneic Hematopoietic Cell Transplantation

Phase 2 Study of Bosutinib in Japanese Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Pre-Transplant Serum Beta-2 Microglobulin Level Is a Potential Novel Prognostic Marker for Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Noninvasive Diagnostic Approach By per Rectal Portal Scintigraphy for Sinusoidal Obstruction Syndrome after Allogeneic Hematopoietic Cell Transplantation

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)

Results from the 208-Week (4-Year) Follow-up of RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera (PV)

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Post-Transplant Cyclophosphamide Contributes to Impaired Graft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model

Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation

Combination of Frailty Status and Comorbidity Score Improves the Prediction of Survival in Patients with Myelodysplastic Syndrome Due to Good Predictive Capability for Infection-Related Mortality

Short-Term Fasting Induces Cell Cycle Arrest of Immature Hematopoietic Cells and Increases the Number of Naive T Cells in the Bone Marrow of Mice

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only